Intestinal-lysis non-steroidal antipyretic-antalgic anti-inflammatory agent and preparation thereof

A technology of antipyretic, analgesic and anti-inflammatory drugs, which is applied in the direction of antipyretics, anti-inflammatory agents, non-central analgesics, etc. It can solve the problem of different selection effects and achieve good absorption effect

Inactive Publication Date: 2009-01-28
QINGDAO KDN BIOTECH +1
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The use of non-steroidal anti-inflammatory drugs (NSAIDs) in human clinical practice After more than a century of continuous research and clinical use, it has been found that most antipyretic, analgesic and anti-inflammatory drugs have an effect on COX-1 and COX -2 is not selective, just different drugs have different selective effects on COX-1 and COX-2

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1: First use 1000ml (ethanol: water = 80: 20) solution to heat and dissolve 45g of hypromellose peptidate (HP55), then add 150g of diclofenac sodium, heat and stir until dissolved and clear, then concentrate to thicken while stirring. shape, cooled, and dried to obtain enteric-coated clothes. Coating weight gain: 22.98%.

[0025] Determination of encapsulation efficiency: According to the dissolution rate of the coating in acidic medium is 0 (this conclusion can be drawn in the following dissolution test), it is advisable to quickly filter the coating after stirring in 0.1mol / L HCl solution (PH=1.0) , the encapsulated drug will not dissolve, but the free drug will dissolve, the amount of free drug can be measured W free, in addition the total amount of drug W is known, according to encapsulation efficiency=(W total-W free) / W total × 100%, the calculated encapsulation efficiency is 98.1%.

[0026] Dissolution determination: according to the second method in the...

Embodiment 2

[0029] Example 2: First heat and dissolve 15g of hypromellose peptidate (HP55) with 800ml (ethanol: water = 80: 20) solution, then add 150g of diclofenac sodium, heat and stir until dissolved and clear, and concentrate to thick while stirring shape, cooled, and dried to obtain enteric-coated clothes. Coating weight gain: 9.0%.

[0030] Determination of encapsulation efficiency: According to the dissolution rate of the coating in acidic medium is 0 (this conclusion can be drawn in the following dissolution test), it is advisable to quickly filter the coating after stirring in 0.1mol / L HCl solution (PH=1.0) , the encapsulated drug will not dissolve, but the free drug will dissolve, the amount of free drug can be measured W free, in addition the total amount of drug W is known, according to encapsulation efficiency=(W total-W free) / W total × 100%, the calculated encapsulation efficiency is 92.5%.

[0031]Dissolution determination: according to the second method in the dissoluti...

Embodiment 3

[0034] Example 3: First heat and dissolve 5g of hypromellose peptidate (HP55) with 500ml (ethanol: water = 80:20) solution, then add 100g of diclofenac sodium, heat and stir until dissolved and clear, and spray dry to obtain enteric coating Pack clothing. Coating weight gain: 4.72%.

[0035] Determination of encapsulation efficiency: According to the dissolution rate of the coating in acidic medium is 0 (this conclusion can be drawn in the following dissolution test), it is advisable to quickly filter the coating after stirring in 0.1mol / L HCl solution (PH=1.0) , the encapsulated drug will not dissolve, but the free drug will dissolve, the amount of free drug can be measured W free, in addition the total amount of drug W is known, according to encapsulation efficiency=(W total-W free) / W total × 100%, the calculated encapsulation efficiency is 90.7%.

[0036] Dissolution determination: according to the second method in the dissolution determination method of appendix XC of Ch...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to non-sterides antipyretic-analgesic and anti-inflammatory drug with enteric solubility and the preparation thereof; when the non-sterides antipyretic-analgesic and anti-inflammatory drug is taken orally, the confessed side effects such as nausea, emesis, gastric ulcer, gastric perforation, gastrorrhagia, edema, and the like on the gastrointestinal tract of human body and animals caused by the drug are avoided.

Description

technical field [0001] The invention relates to a preparation method of an enteric-coated preparation of a non-steroidal antipyretic, analgesic and anti-inflammatory drug. Background technique [0002] Nonsteroidal antiinflammatory drugs (NSAIDs) are antipyretic, analgesic and anti-inflammatory drugs commonly used clinically, and are widely used in rheumatic diseases, chronic inflammatory arthritis, and fever and pain diseases caused by various reasons . [0003] In the more than a century since aspirin was launched on the market in 1898, nonsteroidal antiinflammatory drugs (NSAIDs) have increased to more than a hundred varieties, which can be divided into formic acids, also known as salicylates, according to their chemical structures. Acids (representing the drugs aspirin, diclonisal, etc.); acetic acids (representing the drugs diclofenac, indomethacin, sulindac and etofenamate); propionic acids (representing the drugs ibuprofen, ketoprofen Fen, fenbufen, naproxen, oxapro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K45/00A61K47/30A61P29/00
Inventor 袁卫
Owner QINGDAO KDN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap